Quenet Torrent Institute: R&D Intensive Centre in Oncology

Innovation at the Heart of Quenet Torrent Institute

Quenet Torrent Institute has been recognised as an R&D intensive organisation, reflecting its deep commitment to innovation in oncological surgery, clinical research and the development and implementation of novel therapeutic strategies for patients with complex cancers.

Research Activities

PIPAC development: Dr. Juan José Torrent has been instrumental in developing PIPAC in Spain and contributing to international protocols and outcome studies. CRS+HIPEC outcomes: Our institutional series contributes to international registries including PSOGI and RENAPE, providing real-world data on peritoneal surface surgery outcomes. Clinical trials: Participation in national and international trials evaluating new systemic agents, locoregional delivery methods and surgical techniques. Technology integration: Research into robotic surgery, augmented reality and intraoperative imaging.

Academic Collaborations

Collaboration with major Spanish and European universities, hospitals and research centres. Publication of outcomes data in peer-reviewed international journals. Active participation in ESSO, PSOGI, SEOQ and other scientific societies. International training and fellowship programmes hosting surgeons from multiple countries.

Benefit to Patients

Being treated at a research-active centre means access to emerging treatments through clinical trials, care based on the most current evidence, contribution to improving outcomes for future patients, and the oversight and academic accountability that comes with research activity.